<code id='5D8CC930D8'></code><style id='5D8CC930D8'></style>
    • <acronym id='5D8CC930D8'></acronym>
      <center id='5D8CC930D8'><center id='5D8CC930D8'><tfoot id='5D8CC930D8'></tfoot></center><abbr id='5D8CC930D8'><dir id='5D8CC930D8'><tfoot id='5D8CC930D8'></tfoot><noframes id='5D8CC930D8'>

    • <optgroup id='5D8CC930D8'><strike id='5D8CC930D8'><sup id='5D8CC930D8'></sup></strike><code id='5D8CC930D8'></code></optgroup>
        1. <b id='5D8CC930D8'><label id='5D8CC930D8'><select id='5D8CC930D8'><dt id='5D8CC930D8'><span id='5D8CC930D8'></span></dt></select></label></b><u id='5D8CC930D8'></u>
          <i id='5D8CC930D8'><strike id='5D8CC930D8'><tt id='5D8CC930D8'><pre id='5D8CC930D8'></pre></tt></strike></i>

          Home / knowledge / hotspot

          hotspot


          hotspot

          author:knowledge    Page View:967
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In